Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Recruiting · NCT03609398 · Registry updated 2021-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine | Bunyaviridae infectious disease, Digestive System Diseases, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2021-02-11 | NCT03609398 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| U.S. Army Medical Research and Development Command | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Special Immunization Program, Division of Medicine, USAMRIID | Fort Deterick | United States | 1 |